Fingerprint
Dive into the research topics of 'A phase II study of α-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II study of α-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma
Frank L. Meyskens, Edwin M. Kingsley, Theodore Glattke, Lois Loescher, Ann Booth
Research output: Contribution to journal › Article › peer-review
66
Scopus
citations